Vapreotide: Difference between revisions
Jump to navigation
Jump to search
Created page with "{{Drugbox | IUPAC_name = 2-Amino-''N''-[10-(4-aminobutyl)-4-{[1-carbamoyl-2-(1''H''-indol-2-yl)ethyl]carbamoyl}-16-[(4-hydroxyphenyl)methyl]-13-(1''H''-indol-3-ylmethyl)-6,9,1..." |
No edit summary |
||
Line 1: | Line 1: | ||
{{Drugbox | {{Drugbox | ||
| IUPAC_name = 2-Amino-''N''-[10-(4-aminobutyl)-4-{[1-carbamoyl-2-(1''H''-indol-2-yl)ethyl]carbamoyl}-16-[(4-hydroxyphenyl)methyl]-13-(1''H''-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-(propan-2-yl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-19-yl]-3-phenylpropanamide | | IUPAC_name = 2-Amino-''N''-[10-(4-aminobutyl)-4-{[1-carbamoyl-2-(1''H''-indol-2-yl)ethyl]carbamoyl}-16-[(4-hydroxyphenyl)methyl]-13-(1''H''-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-(propan-2-yl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-19-yl]-3-phenylpropanamide | ||
| image = Vapreotide. | | image = Vapreotide.png | ||
| width = 200 | | width = 200 | ||
| alt = | | alt = | ||
Line 72: | Line 72: | ||
{{Pituitary and hypothalamic hormones and analogues}} | {{Pituitary and hypothalamic hormones and analogues}} | ||
[[Category: | [[Category:Drug]] | ||
[[Category:Lactams]] | [[Category:Lactams]] | ||
[[Category:Peptides]] | [[Category:Peptides]] | ||
[[Category:Hormonal agents]] | [[Category:Hormonal agents]] | ||
Revision as of 19:02, 7 April 2015
Clinical data | |
---|---|
Trade names | Sanvar |
Synonyms | Octastatin |
ATC code | |
Pharmacokinetic data | |
Elimination half-life | 30 minutes |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
PubChem SID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C57H70N12O9S2 |
Molar mass | 1131.37 g/mol |
3D model (JSmol) | |
Density | 1.4 g/cm3 |
Boiling point | 1,540.9 °C (2,805.62 °F) |
|
Vapreotide (Sanvar) is a synthetic somatostatin analog. It is used in the treatment of esophageal variceal bleeding in patients with cirrhotic liver disease and AIDS-related diarrhea.[1]